Twist Bioscience Corp·4

Nov 6, 5:02 PM ET

Ever Alpha Fund L.P. 4

4 · Twist Bioscience Corp · Filed Nov 6, 2018

Insider Transaction Report

Form 4
Period: 2018-11-02
Transactions
  • Conversion

    Common Stock

    2018-11-02+3,294,9613,294,961 total
  • Conversion

    Series D Preferred Stock

    2018-11-023,294,9610 total
    Common Stock (3,294,961 underlying)
Footnotes (2)
  • [F1]The Series D Preferred Stock has no expiration date and will convert into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering.
  • [F2]Ever Glory Limited is the general partner of Ever Alpha Fund L.P. Ever Glory Limited is a wholly owned subsidiary of Guangfa Xinde Capital Management Limited. Guangfa Xinde Capital Management Limited is a wholly owned subsidiary of Guangfa Investment (Hong Kong) Company Limited. Guangfa Investment (Hong Kong) Company Limited is a wholly owned subsidiary of Guangfa Holding (Hong Kong) Corporation Limited.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION